An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
出版年份 2017 全文链接
标题
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
作者
关键词
-
出版物
npj Vaccines
Volume 2, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-05-30
DOI
10.1038/s41541-017-0016-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Probable Hospital Cluster of H7N9 Influenza Infection
- (2016) Amber Farooqui et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost
- (2015) Julie E. Ledgerwood et al. Contemporary Clinical Trials
- Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response
- (2015) Lisa A. Jackson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
- (2015) Mahdee Sobhanie et al. JOURNAL OF INFECTIOUS DISEASES
- Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults
- (2015) Michelle C. Crank et al. PLoS One
- DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial
- (2015) Julie E. Ledgerwood et al. PLoS One
- Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins
- (2014) Kristy Blanchfield et al. Influenza and Other Respiratory Viruses
- Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant
- (2014) Mark J. Mulligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pandemic potential of avian influenza A (H7N9) viruses
- (2014) Tokiko Watanabe et al. TRENDS IN MICROBIOLOGY
- Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine
- (2014) Tara M. Babu et al. VACCINE
- Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013
- (2013) A Zhang et al. Eurosurveillance
- Avian-Origin Influenza A(H7N9) Infection in Influenza A(H7N9)–Affected Areas of China: A Serological Study
- (2013) Shigui Yang et al. JOURNAL OF INFECTIOUS DISEASES
- DNA Priming Prior to Inactivated Influenza A(H5N1) Vaccination Expands the Antibody Epitope Repertoire and Increases Affinity Maturation in a Boost-Interval–Dependent Manner in Adults
- (2013) Surender Khurana et al. JOURNAL OF INFECTIOUS DISEASES
- Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
- (2013) Julie E. Ledgerwood, Kathryn Zephir, Zonghui Hu, Chih-Jen Wei, LeeJah Chang, Mary E. Enama, Cynthia S. Hendel, Sandra Sitar, Robert T. Bailer, Richard A. Koup, John R. Mascola, Gary J. Nabel, Barney S. Graham et al. JOURNAL OF INFECTIOUS DISEASES
- Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice
- (2013) Jessica A. Belser et al. NATURE
- Characterization of H7N9 influenza A viruses isolated from humans
- (2013) Tokiko Watanabe et al. NATURE
- Global Concerns Regarding Novel Influenza A (H7N9) Virus Infections
- (2013) Timothy M. Uyeki et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
- (2013) Louis F. Fries et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
- (2013) Rongbao Gao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
- (2013) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial
- (2013) Barney S. Graham et al. PLoS One
- Infectivity, Transmission, and Pathology of Human-Isolated H7N9 Influenza Virus in Ferrets and Pigs
- (2013) H. Zhu et al. SCIENCE
- Correlates of protection to influenza virus, where do we go from here?
- (2013) Rebecca Cox Human Vaccines & Immunotherapeutics
- Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract
- (2013) Michael CW Chan et al. Lancet Respiratory Medicine
- Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans
- (2012) J. E. Ledgerwood et al. Clinical and Vaccine Immunology
- A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine
- (2012) Robert B. Couch et al. PLoS One
- A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
- (2011) Julie E. Ledgerwood et al. JOURNAL OF INFECTIOUS DISEASES
- DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
- (2011) Julie E Ledgerwood et al. LANCET INFECTIOUS DISEASES
- Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
- (2010) C.-J. Wei et al. SCIENCE
- A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
- (2009) Rebecca J. Cox et al. VACCINE
- Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses
- (2008) Shixia Wang et al. VACCINE
- A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
- (2008) Julie E. Martin et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More